Apr 05, 2012, 10.58 PM IST
Bio-pharma major Biocon on expansion mode.
Biocon is banking on a strong research pipeline. The company's focus on oral insulin will continue.
Biocon stock price
On December 13, 2013, at 12:20 hrs Biocon was quoting at Rs 389.00, down Rs 2.35, or 0.6 percent. The 52-week high of the share was Rs 408.80 and the 52-week low was Rs 255.00.
The company's trailing 12-month (TTM) EPS was at Rs 15.02 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 25.9. The latest book value of the company is Rs 110.34 per share. At current value, the price-to-book value of the company is 3.53.
Action in Biocon
Video of the day
Dec 13 2013, 10:39
- in MARKET OUTLOOK
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.